Cadre Holdings, Inc. (CDRE) stock
CDRENYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 16/3023% above fair value
$31.88−0.53 (-1.64%)
Close on Nov 18, 2026Market cap $1.37BP/E 39.4Yield 1.19%
Cadre shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Cadre's shares outstanding was 43M at Jun 30, 2026. For fiscal 2025 it was 43M, up 7.7% from the year before. The highest annual figure on record is 43M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 43M | +7.7% |
| FY2024 | Dec 31, 2024 | 40M | +6.4% |
| FY2023 | Dec 31, 2023 | 38M | +5.0% |
| FY2022 | Dec 31, 2022 | 36M | +26.3% |
| FY2021 | Dec 31, 2021 | 29M | +4.1% |
| FY2020 | Dec 31, 2020 | 27M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 43M | +6.0% |
| Q1 FY2026 | Mar 31, 2026 | 43M | +5.8% |
| Q4 FY2025 | Dec 31, 2025 | 51M | +24.1% |
| Q3 FY2025 | Sep 30, 2025 | 41M | +0.1% |
| Q2 FY2025 | Jun 30, 2025 | 41M | +0.2% |
| Q1 FY2025 | Mar 31, 2025 | 41M | +6.3% |
| Q4 FY2024 | Dec 31, 2024 | 41M | +7.3% |
| Q3 FY2024 | Sep 30, 2024 | 41M | +8.0% |
| Q2 FY2024 | Jun 30, 2024 | 41M | +7.9% |
| Q1 FY2024 | Mar 31, 2024 | 39M | +2.5% |
| Q4 FY2023 | Dec 31, 2023 | 38M | +2.1% |
| Q3 FY2023 | Sep 30, 2023 | 38M | +0.5% |
| Q2 FY2023 | Jun 30, 2023 | 38M | +6.1% |
| Q1 FY2023 | Mar 31, 2023 | 38M | +9.2% |
| Q4 FY2022 | Dec 31, 2022 | 37M | +17.1% |
| Q3 FY2022 | Sep 30, 2022 | 38M | +37.3% |
| Q2 FY2022 | Jun 30, 2022 | 36M | +29.9% |
| Q1 FY2022 | Mar 31, 2022 | 34M | +25.3% |
| Q4 FY2021 | Dec 31, 2021 | 32M | +16.2% |
| Q3 FY2021 | Sep 30, 2021 | 27M | 0.0% |
| Q2 FY2021 | Jun 30, 2021 | 27M | – |
| Q1 FY2021 | Mar 31, 2021 | 27M | – |
| Q4 FY2020 | Dec 31, 2020 | 27M | – |
| Q3 FY2020 | Sep 30, 2020 | 27M | – |
See a number that looks wrong?